These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7123512)

  • 1. Isolation and partial characterization of two distinct types of antithrombin III from rabbit.
    Carlson TH; Atencio AC
    Thromb Res; 1982 Jul; 27(1):23-34. PubMed ID: 7123512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
    Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
    Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
    Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of mammalian antithrombin III].
    Bashkov GV; Kalishevskaia TM; Strukova SM
    Biokhimiia; 1989 Nov; 54(11):1797-803. PubMed ID: 2627551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on antithrombin III in normal plasma and serum.
    Sas G; Pepper DS; Cash JD
    Br J Haematol; 1975 Jul; 30(3):265-72. PubMed ID: 1201212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
    Heger A; Grunert T; Schulz P; Josic D; Buchacher A
    Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW; Eggleton CA; Mahmoud M
    Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.
    Ambruso DR; Leonard BD; Bies RD; Jacobson L; Hathaway WE; Reeve EB
    Blood; 1982 Jul; 60(1):78-83. PubMed ID: 7082848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-step method for the isolation of antithrombin III.
    Wickerhauser M; Williams C
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.